Ochi H - Search Results

1

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.

Tsuge M, Murakami E, Imamura M, Abe H, Miki D, Hiraga N, Takahashi S, Ochi H, Nelson Hayes C, Ginba H, Matsuyama K, Kawakami H, Chayama K. Tsuge M, et al. Among authors: ochi h. J Gastroenterol. 2013 Oct;48(10):1188-204. doi: 10.1007/s00535-012-0737-2. Epub 2013 Feb 9. J Gastroenterol. 2013. PMID: 23397114

2

Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine.

Hatakeyama T, Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Kawakami Y, Fujimoto Y, Ochi H, Abe H, Maekawa T, Kawakami H, Yatsuji H, Aisaka Y, Kohno H, Aimitsu S, Chayama K. Hatakeyama T, et al. Among authors: ochi h. Hepatology. 2007 May;45(5):1179-86. doi: 10.1002/hep.21581. Hepatology. 2007. PMID: 17465002

3

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.

Tsukada H, Ochi H, Maekawa T, Abe H, Fujimoto Y, Tsuge M, Takahashi H, Kumada H, Kamatani N, Nakamura Y, Chayama K. Tsukada H, et al. Among authors: ochi h. Gastroenterology. 2009 May;136(5):1796-805.e6. doi: 10.1053/j.gastro.2009.01.061. Epub 2009 Jan 31. Gastroenterology. 2009. PMID: 19208361 Free article.

4

G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection.

Noguchi C, Imamura M, Tsuge M, Hiraga N, Mori N, Miki D, Kimura T, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Tateno C, Yoshizato K, Chayama K. Noguchi C, et al. Among authors: ochi h. J Infect Dis. 2009 Jun 1;199(11):1599-607. doi: 10.1086/598951. J Infect Dis. 2009. PMID: 19432545

5

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Hashimoto Y, Ochi H, Abe H, Hayashida Y, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Nelson Hayes C, Ohishi W, Kubo M, Tsunoda T, Kamatani N, Nakamura Y, Chayama K. Hashimoto Y, et al. Among authors: ochi h. J Med Virol. 2011 Jun;83(6):981-8. doi: 10.1002/jmv.22028. J Med Virol. 2011. PMID: 21503910

6

IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients.

Ohnishi M, Tsuge M, Kohno T, Zhang Y, Abe H, Hyogo H, Kimura Y, Miki D, Hiraga N, Imamura M, Takahashi S, Ochi H, Hayes CN, Tanaka S, Arihiro K, Chayama K. Ohnishi M, et al. Among authors: ochi h. J Gastroenterol. 2012 Jul;47(7):834-44. doi: 10.1007/s00535-012-0550-y. Epub 2012 Feb 18. J Gastroenterol. 2012. PMID: 22350701

7

Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.

Kawaoka T, Takahashi S, Takaki S, Hiramatsu A, Waki K, Hiraga N, Miki D, Tsuge M, Imamura M, Kawakami Y, Aikata H, Ochi H, Onoe T, Tashiro H, Ohdan H, Chayama K. Kawaoka T, et al. Among authors: ochi h. J Gastroenterol Hepatol. 2012 Sep;27(9):1467-72. doi: 10.1111/j.1440-1746.2012.07129.x. J Gastroenterol Hepatol. 2012. PMID: 22432893

8

Identification of novel HCV deletion mutants in chronic hepatitis C patients.

Kohno T, Tsuge M, Hayes CN, Hatakeyama T, Ohnishi M, Abe H, Miki D, Hiraga N, Imamura M, Takahashi S, Ochi H, Tanaka S, Chayama K. Kohno T, et al. Among authors: ochi h. Antivir Ther. 2012;17(8):1551-61. doi: 10.3851/IMP2265. Epub 2012 Jul 25. Antivir Ther. 2012. PMID: 22837441

9

Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis.

Nagaoki Y, Aikata H, Kobayashi T, Fukuhara T, Masaki K, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Tsuge M, Hiramatsu A, Imamura M, Hyogo H, Kawakami Y, Takahashi S, Ochi H, Chayama K. Nagaoki Y, et al. Among authors: ochi h. J Gastroenterol. 2013 Jul;48(7):847-55. doi: 10.1007/s00535-012-0679-8. Epub 2012 Oct 5. J Gastroenterol. 2013. PMID: 23053422

10

Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.

Arataki K, Hayes CN, Akamatsu S, Akiyama R, Abe H, Tsuge M, Miki D, Ochi H, Hiraga N, Imamura M, Takahashi S, Aikata H, Kawaoka T, Kawakami Y, Ohishi W, Chayama K. Arataki K, et al. Among authors: ochi h. J Med Virol. 2013 May;85(5):789-98. doi: 10.1002/jmv.23540. J Med Virol. 2013. PMID: 23508904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters